| Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan K Asghar, A Loya, I Ali Rana, M Tahseen, M Ishaq, A Farooq, ... Cancer Management and Research 11, 475-481, 2019 | 36 | 2019 |
| Indoleamine 2, 3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma K Asghar, A Farooq, B Zulfiqar, MU Rashid World Journal of Gastroenterology 23 (13), 2286, 2017 | 32 | 2017 |
| Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives B Zulfiqar, A Farooq, S Kanwal, K Asghar Frontiers in Pharmacology 13, 1035171, 2022 | 15 | 2022 |
| Review of 10 years of research on breast cancer patients: focus on indoleamine 2, 3-dioxygenase K Asghar, A Farooq, B Zulfiqar, A Loya World Journal of Clinical Oncology 12 (6), 429, 2021 | 7 | 2021 |
| Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan K Asghar, A Loya, I Ali Rana, M Abu Bakar, A Farooq, M Tahseen, ... Asian Pacific Journal of Cancer Prevention 20 (11), 3521-3525, 2019 | 7 | 2019 |
| Clinical characteristics of COVID-19-infected cancer patients in Pakistan: Differences between survivors and non-survivors K Asghar, M Abu Bakar, MJ Akram, A Farooq, K Siddique, IA Rana, J Ali, ... Frontiers in oncology 11, 655634, 2021 | 6 | 2021 |
| Indoleamine 2, 3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma A Farooq, B Zulfiqar, K Asghar Journal of Cancer & Allied Specialties 9 (1), 2023 | 2 | 2023 |
| COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management K Asghar, M Abu Bakar, S Ashfaq, A Munir Alvi, W Shafiq, U Azmat, ... Frontiers in Oncology 12 (922579), 10, 2022 | 2 | 2022 |
| Forkhead box P3 and indoleamine 2, 3-dioxygenase co-expression in Pakistani triple negative breast cancer patients K Asghar, A Loya, IA Rana, MA Bakar, A Farooq, M Tahseen, M Ishaq, ... World Journal of Clinical Oncology 11 (12), 1018, 2020 | 2 | 2020 |
| Expression of PD-L1 clones (22C3 and 28-8) in hepatocellular carcinoma: a tertiary cancer care hospital experience K Asghar, S Bashir, M Hassan, A Farooq, MA Bakar, S Bilal, M Hameed, ... Egyptian Liver Journal 14 (1), 4, 2024 | 1 | 2024 |
| Community Outreach and Engagement in Cancer Research Through a Biobank Clinic at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan A Farooq, M Hassan, A Loya, K Asghar Cureus 16 (2), 2024 | | 2024 |
| PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients K Asghar, S Bashir, I Ali Rana, M Abu Bakar, A Farooq, M Hassan, Z Asif, ... Journal of Hepatocellular Carcinoma, 921-934, 2023 | | 2023 |
| High Indoleamine 2, 3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients K Asghar, IA Rana, MA Bakar, K Hasham, M Tahseen, S Bilal, ... Asian Pacific Journal of Cancer Prevention: APJCP 24 (5), 1591, 2023 | | 2023 |
| Experiences of Shaukat Khanum Memorial Cancer Hospital and Research Centre Biobank during COVID-19 Pandemic K Asghar, A Farooq, A Loya Asian Pacific Journal of Cancer Prevention 23 (9), 2879-2880, 2022 | | 2022 |
